EMPEROR-Preserved: effect of empagliflozin on cardiovascular death and heart failure hospitalisations in patients with heart failure with a preserved ejection fraction, with and without diabetes

27 August 2021 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Hot Line - EMPEROR-Preserved / EMPEROR-Pooled Heart Failure with Preserved Ejection Fraction (HFpEF) ESC Premium Access ESC Congress 2021 - The Digital Experience

ESC 365 is supported by

ESC 365 is supported by